Navigation Links
Dilon Technologies Leads Molecular Breast Imaging Expansion
Date:2/10/2009

- Clinicians Embrace MBI Technique Breast-Specific Gamma Imaging (BSGI) Resulting in Record 2008 Sales

NEWPORT NEWS, Va., Feb. 10 /PRNewswire/ -- Dilon Technologies, Inc., a leader in molecular breast imaging, today announced record sales for 2008 highlighted by the strongest fourth quarter in the company's history. The company achieved a 35 percent increase in sales from 2007 to 2008 as molecular breast imaging gains nationwide exposure and acceptance.

Breast-Specific Gamma Imaging (BSGI) - a molecular imaging procedure, along with breast MRI, are expected to increase at a compound growth rate of 28 percent over the next five years, according to the Millennium Research Group's U.S. Markets for Women's Health Imaging Systems report. It also states that Dilon Technologies is leading the way to global availability of molecular breast imaging. Dilon's cornerstone product, the Dilon 6800 Gamma Camera is a high-resolution, compact gamma camera optimized to perform BSGI.

"We had a particularly strong finish to the year, breaking through a monthly sales record in December," said Bob Moussa, President and CEO of Dilon Technologies. "Breast imaging centers across the country and around the world are using BSGI to pave the way to effective diagnosis of breast cancer."

BSGI is an adjunctive molecular breast imaging technique to mammography that can see lesions independent of tissue density and discover early stage cancers. With BSGI, the patient receives a pharmaceutical tracing agent that is absorbed by all the cells in the body. Due to their increased rate of metabolic activity, cancerous cells in the breast absorb a greater amount of the tracing agent than normal, healthy cells and generally appear as "hot spots" on the BSGI image.

Dilon's molecular imaging technology is already available in Europe, parts of the Asian-Pacific basin, the Caribbean, and soon to be in Lat
'/>"/>

SOURCE Dilon Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Dilon Technologies Slant15(TM) and LEHR Collimators Enhance Imaging Capabilities
2. Dilon Technologies Signs Amerinet for Breast-Specific Gamma Imaging
3. Dilon Technologies Announces National Agreement with MedAssets
4. Settlement Reached Between Dilon Technologies and Naviscan on Patent Rights
5. Dilon Technologies Appoints New VP of Sales & Business Development
6. Dilon Technologies Explores Improvements in Molecular Breast Imaging
7. China Medical Technologies to Announce Financial Results for the Third Fiscal Quarter Ended December 31, 2008 on March 2, 2009
8. VNUS Medical Technologies to Present at the Roth 21st Annual OC Growth Stock Conference
9. Greenway Medical Technologies and Navicure Form Partnership to Streamline Claims Management Process
10. ReBuilder Medical Technologies, Inc. to Change Name to American Med Tech
11. Advanced Wound Technologies Mid-Atlantic, Inc. Announces Name Change and Reverse Stock Split
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... (PRWEB) April 20, 2015 Saint Joseph Regional ... 15 Top Health Systems by Truven Health Analytics, a leading ... quality of healthcare. SJRMC has been recognized by Truven Health ... the past four years. , According to Truven Health Analytics' ... Health Systems, in matchups with their peers, set the standard ...
(Date:4/20/2015)... A recent cross-sectional survey involving fibromyalgia patients ... 10 most beneficial therapies for fibromyalgia, no drugs were mentioned, ... only approved drugs were named. , “The biggest problem ... is only felt as long as the patient is taking ... “On the other hand, aerobic exercise and other non-drug approaches ...
(Date:4/20/2015)... 2015 Western Connecticut Health Network ... NEA-BC, FAAN who was named The Beatrice Hofstadter ... in September 2014, is transitioning from her current ... the development of Western Connecticut Health Network’s Nurse ... Donahue will be responsible for the identification and ...
(Date:4/20/2015)... 2015 Advance Home Care Supply ... that many customers would prefer not to share with others. ... a discreet delivery method allowing customers to order the products ... home without fear of a neighbor or passerby knowing what ... available now on all orders and no minimum order limit ...
(Date:4/20/2015)... Genuine fat loss results can seem virtually impossible ... the past. But what failed dieters and gym-goers don’t realize ... by adhering to five simple principles. , 1. Nutrition, No ... hours one spends working at the gym, a poor diet ... nutritional mean plan does not mean starvation, calorie counting or ...
Breaking Medicine News(10 mins):Health News:SJRMC Named a 15 Top Health System by Truven Health Analytics 2Health News:SJRMC Named a 15 Top Health System by Truven Health Analytics 3Health News:Medical Doctor in Huntsville Reveals That Aerobic Exercise Offers Best Results in Fibromyalgia Treatment 2Health News:Nursing Executive to Develop and Lead Nursing Leadership Program at Western Connecticut Health Network 2Health News:Advance Home Care Supply Proud to Offer Discreet Delivery For All Orders 2Health News:Advance Home Care Supply Proud to Offer Discreet Delivery For All Orders 3Health News:Guarantee Fat Loss Results With 5 Easy Tips 2Health News:Guarantee Fat Loss Results With 5 Easy Tips 3
... light to medium smokers, daily intake of non-steroidal anti-inflammatory drugs ... ,Norwegian scientists, who had conducted the studies, had said ... 65% less chance of having oral cancer than others, when ... suggested that NSAID might have anti carcinogenic effect on smokers ...
... improve the rate of recovery for the patients. Patients who had ... // having a favorable recovery than persons who have not been ... had the chance of 2.6 times more of a favorable recovery ... who had ischemic stroke to assess the usefulness of statins before ...
... a report prepared for the Health And Safety Executive, a ... of the employees,// researchers had found out that working in ... people work during nights, the levels of melatonin, or the ... with the new sleep routines. As a result, people do ...
... Technologies had developed a robotic dental drill that can make ... dental surgeon. The drill is all set to bring relief ... less painful than the common manual procedure. ,A dental ... and is generally imbedded in the gum through a long ...
... cancer is enhanced by eating processed meats, said the researchers ... Honolulu. ,Previous studies have tried to relate meat with ... have been proved to enhance carcinogenic growth in the pancreas. ... but the chemical agents that process the meat for long ...
... US department of Agriculture has recently unveiled a new guide to ... different needs. ,Based on the idea that same diet pattern ... on age, sex and the level of activity. The new plan ... gives you a diet chart once you feed in the required ...
Cached Medicine News:
(Date:4/20/2015)... BALTIMORE , April 20, 2015  Ameritox,s Ingenuity ... health clinicians, today presented clinical research at the National ... Orlando, Fla. , showing that nearly 25 percent ... illness (SMI) did not contain the prescribed antipsychotic medication. ... - http://photos.prnewswire.com/prnh/20150420/199663LOGO ...
(Date:4/20/2015)... , April 20, 2015  U.S. pharmacy cost increases ... to drift into the low double-digits by 2016, according to ... retirement and health solutions business of Aon plc ... changes are projected to be 9.5 percent in 2015 and ... Aon Hewitt predicts a similar rate of increase in ...
(Date:4/20/2015)... , April 20, 2015 Eli Lilly ... the investigational medicine ixekizumab was statistically superior to placebo ... (PsA), as demonstrated by the proportion of patients achieving ... assessment that represents a 20 percent reduction in disease ... of Rheumatology response criteria. During the 24-week, Phase 3 ...
Breaking Medicine Technology:Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 2Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 2Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 4Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 2Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 3Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 4
... Inc. (Nasdaq: STRM ) today announced financial ... ended January 31, 2011. Highlights for the ... purchase contracts for add-on licenses with existing clients totaling ... recognized during the quarter; Company completed and ...
... N.J., April 12, 2011 Novartis Pharmaceuticals Corporation ... Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) ... treatment of patients with advanced neuroendocrine tumors (NET) ... provided after presentation of data from the everolimus ...
Cached Medicine Technology:Streamline Health® Solutions Reports Q4 Results 2Streamline Health® Solutions Reports Q4 Results 3Streamline Health® Solutions Reports Q4 Results 4Streamline Health® Solutions Reports Q4 Results 5Streamline Health® Solutions Reports Q4 Results 6Streamline Health® Solutions Reports Q4 Results 7Streamline Health® Solutions Reports Q4 Results 8Streamline Health® Solutions Reports Q4 Results 9Streamline Health® Solutions Reports Q4 Results 10Streamline Health® Solutions Reports Q4 Results 11Streamline Health® Solutions Reports Q4 Results 12Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 2Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 3Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 4Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 5Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 6Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 7Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 8Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 9Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 10
... Right for the typical patient, right ... Medical ICDs, you have the ability to ... when you least expect themeven after implant. ... you need to be prepared in almost ...
... ID and Visitor Control System. A bar code-based ... compare and verify identity of those people authorized ... document interactions with all visitors and staff who ... child patient. It also helps to reduce the ...
... global companies a cost-effective and dependable ... initiatives. With die-cast metal construction, centralized ... options, and complex multi-language font support, ... Plus, the fully integrated RFID reader/encoder ...
... solid, tested XiIIIPlus platform, the R110Xifor ... of on-demand printing flexibility in tag ... such as XML for seamless integration ... inlay positioning, multiple power levels, statistics ...
Medicine Products: